Vitiligo, from Pathogenesis to Therapeutic Advances: State of the Art

Vitiligo, from Pathogenesis to Therapeutic Advances: State of the Art

Vitiligo is an acquired hypopigmentation of the skin due to a progressive selective loss of melanocytes; it has a prevalence of 1–2% and appears as rounded, well-demarcated white macules. The etiopathology of the disease has not been well defined, but multiple factors contribute to melanocyte loss:...

Full description

Bibliographic Details
Main Authors: Federico Diotallevi, Helena Gioacchini, Edoardo De Simoni, Andrea Marani, Matteo Candelora, Matteo Paolinelli, Elisa Molinelli, Annamaria Offidani, Oriana Simonetti
Format: Article
Language:English
Published: MDPI AG 2023-03-01
Series:International Journal of Molecular Sciences
Subjects:
vitiligo
pathogenesis
treatments
afamelanotide
prostaglandin
Janus kinase inhibitors
Online Access:https://www.mdpi.com/1422-0067/24/5/4910

Internet

https://www.mdpi.com/1422-0067/24/5/4910

Similar Items